U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07240142) titled 'Neurotransmitter Levels in Children With Specific Learning Disorder' on Sept. 30.
Brief Summary: The aim of this clinical trial was to measure how specific neurotransmitter levels in children with Specific Learning Disorder (SLD) change compared to controls. The relationship between these markers and the measured markers will be determined both theoretically and experimentally using various neuropsychological tests. The fundamental questions it aims to answer are
Did neurotransmitter levels increase or decrease in the patient group? Are the neurotransmitter levels measured in the neuropsychological tests related? Can the measured n...